Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/04/2003WO2003072039A2 Cosmetic formulations containing l-arginine oligomers
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072034A2 Cyclic peptides and analogs useful to treat allergies
09/04/2003WO2003072031A2 Treatment of disease by inducing cell apoptosis
09/04/2003WO2003072029A2 Methods of extending corneal graft survival
09/04/2003WO2003072018A2 Ricin vaccine and methods of making and using thereof
09/04/2003WO2003072017A2 Macromolecular conjugates and processes for preparing same
09/04/2003WO2003072016A2 Pharmaceutical compositions in particulate form
09/04/2003WO2003071933A2 Novel compositions and methods for cancer
09/04/2003WO2003071927A2 Diagnostics and therapeutics for macular degeneration-related disorders
09/04/2003WO2003064451A3 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
09/04/2003WO2003054007A3 Streptococcus antigens
09/04/2003WO2003048334A3 Immunocytokines with modulated selectivity
09/04/2003WO2003046560A3 Self-assembly molecules
09/04/2003WO2003046003A3 Plasma protease c1 biopolymer markers predictive of alzheimers disease
09/04/2003WO2003045991A3 Complement c3 precursor biopolymer markers predictive of alzheimers disease
09/04/2003WO2003045306A3 Phenoxy amine compounds and compositions for delivering active agents
09/04/2003WO2003039442A3 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
09/04/2003WO2003039438A3 Pna-conjugates for treating chronic myeloid leukaemia (cml)
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003029778A3 Novel secreted proteins and their uses
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003029283A3 Genetic sequences related to bone diseases in the osteopetrotic grey-lethal (gl) mouse
09/04/2003WO2003029270A3 Process for preparing glycopeptide phosphonate derivatives
09/04/2003WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof
09/04/2003WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
09/04/2003WO2003002593A3 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2002103016A3 Human tachykinin-related splice variants and compositions thereof
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002101044A3 Brain expressed gene and protein associated with bipolar disorder
09/04/2003WO2002101002A3 Identification of snps the hgv-v gene
09/04/2003WO2002099107A3 Regulation of human trace amine receptor ta5
09/04/2003WO2002097073A3 Regulation of human phospholipase c delta-like enzyme
09/04/2003WO2002096947A3 The lectin-like domain of thrombomodulin and its therapeutic use
09/04/2003WO2002094870A8 Proteins and nucleic acids encoding same
09/04/2003WO2002089733A3 Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
09/04/2003WO2002083858A8 Methods to inhibit viral replication
09/04/2003WO2002082076A3 Renal cell carcinoma tumor markers
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002078600A3 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA
09/04/2003WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002062823A3 Peptides for facilitating composite receptor expression and translocation of macromolecules
09/04/2003WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof
09/04/2003WO2002059313A3 G-protein coupled receptors and nucleic acids encoding same
09/04/2003WO2002057436A3 Red blood cell from a transgenic animal as vehicle for polypeptide delivery
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002049662A3 Use of the prion protein (prp) for suppression of bax-mediated apoptosis
09/04/2003WO2002049501A3 Local regional chemotherapy and radiotherapy using in situ hydrogel
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002046413A3 Molecules for disease detection and treatment
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof
09/04/2003WO2002045708A3 Use of zwitterionic polysaccharides for the specific modulation of immune processes
09/04/2003WO2002038767A3 G protein-coupled receptor protein and nucleic acid molecules and uses therefor
09/04/2003WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
09/04/2003WO2002032932A3 Urotensin-ii agonists and antagonists
09/04/2003WO2002032376A3 Bile-acid conjugates for providing sustained systemic concentrations of drugs
09/04/2003WO2002024893A3 CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF
09/04/2003WO2002024889A3 Optimized cardiac contraction through differential phosphorylation of myosin
09/04/2003WO2002020769A9 Human and mouse targeting peptides identified by phage display
09/04/2003WO2002013760A9 Methods and compositions for the repair and/or regeneration of damaged myocardium
09/04/2003WO2001092299A3 Adenovirus particles with mutagenized fiber proteins
09/04/2003WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
09/04/2003WO2001085193A3 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
09/04/2003WO2001066595A9 Human fgf-23 gene and gene expression products
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
09/04/2003WO2000040204A3 Methods for treating cystic fibrosis
09/04/2003US20030167534 Method of producing heteromultimeric mammalian proteins in plants
09/04/2003US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
09/04/2003US20030167490 Gene expression inhibiton/knockout; serpins; fusion proteins
09/04/2003US20030167489 For transgenic mice that produce high levels of humanizing antibodies; immunoglobulins
09/04/2003US20030167483 Analyzing; genetic engineering; transgenic animals, plants
09/04/2003US20030167480 Diagnosis, therapy of cancer using antibodies; detcting, calibration binding
09/04/2003US20030167479 Diagnosis of vascular system disease; measuring Dna in test sample; calibration
09/04/2003US20030167478 Epsin protein detected in injuries; controlling cell differentiation, cell proliferation
09/04/2003US20030167261 Small-footprint applicative query interpreter method, system and program product
09/04/2003US20030167129 Antiinflammatory agents; detecting binding to cellular library; separation; calibration
09/04/2003US20030166944 TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme
09/04/2003US20030166913 Novel beta-defensins
09/04/2003US20030166912 Novel beta-defensins
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166910 Bone morphogenic protein
09/04/2003US20030166909 EGF motif protein, EGFL6 materials and methods
09/04/2003US20030166906 Hybrid polynucleotides; modulate immunology response
09/04/2003US20030166904 Human narcolepsy gene
09/04/2003US20030166900 Isolated nucleic acids; analgesics, antiinflammatory agents
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166898 Myelin oligodendrocyte glycoprotein-like protein (MOGp)
09/04/2003US20030166897 Diagnosis, therapy cancer; transgenic animal
09/04/2003US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders
09/04/2003US20030166887 Diagnosis, therapy of bone disorders; modulation cell differentiation
09/04/2003US20030166883 Genetic engineering; drug screening
09/04/2003US20030166882 Novel polypeptide
09/04/2003US20030166877 Reducing the immunogenicity of fusion proteins
09/04/2003US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
09/04/2003US20030166875 Fibroblast growth factor homologous factor-2 and methods of use
1 ... 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 ... 3163